Johan Linderoth

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study
    Johan Linderoth
    Department of Oncology, Lund University Hospital, 221 85 Lund, Sweden
    Clin Cancer Res 9:722-8. 2003
  2. ncbi CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
    Johan Linderoth
    Department of Oncology, Institution of Clinical Sciences, Lund University Hospital, Lund, Sweden
    Leuk Lymphoma 48:1774-9. 2007
  3. doi CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Karin Rydström
    Department of Oncology, Institution of Clinical Sciences, Lund University and Lund University Hospital, Lund, Sweden
    Leuk Lymphoma 51:1643-8. 2010
  4. doi Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma
    Karin Rydström
    Department of Oncology, Institution of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden
    Leuk Lymphoma 53:1764-8. 2012
  5. doi Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
    Johan Linderoth
    Department of Oncology, Lund University Hospital, Lund, Sweden
    Br J Haematol 141:423-32. 2008
  6. ncbi Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma
    Johan Linderoth
    Department of Oncology, Lund University Hospital, Lund, Sweden
    Eur J Haematol 79:146-9. 2007
  7. doi A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus
    Mats Ehinger
    Departments of Pathology, Lund University Hospital, Lund, Sweden
    Am J Clin Pathol 129:630-8. 2008
  8. ncbi Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
    Mattias Berglund
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Mod Pathol 18:1113-20. 2005
  9. ncbi Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN
    Marie Fridberg
    Department of Tumor Biology, Lund University, Malmo University Hospital, Malmo, Sweden
    Leuk Lymphoma 48:2221-32. 2007

Collaborators

Detail Information

Publications9

  1. ncbi Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study
    Johan Linderoth
    Department of Oncology, Lund University Hospital, 221 85 Lund, Sweden
    Clin Cancer Res 9:722-8. 2003
    ....
  2. ncbi CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
    Johan Linderoth
    Department of Oncology, Institution of Clinical Sciences, Lund University Hospital, Lund, Sweden
    Leuk Lymphoma 48:1774-9. 2007
    ..CD23 was positive in 10% and expression did not correlate with prognosis. In conclusion, the prognostic effect of CD40 expression was confirmed, but did not correlate with GC-phenotype or T-cell infiltration...
  3. doi CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    Karin Rydström
    Department of Oncology, Institution of Clinical Sciences, Lund University and Lund University Hospital, Lund, Sweden
    Leuk Lymphoma 51:1643-8. 2010
    ..Additional and larger studies are necessary, regarding the immunohistochemical robustness of CD40 and the biological mechanisms that contribute to the superior prognosis in CD40-expressing DLBCL...
  4. doi Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma
    Karin Rydström
    Department of Oncology, Institution of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden
    Leuk Lymphoma 53:1764-8. 2012
    ..A high intratumoral inflammatory reaction may correlate with an increased autologous tumor response, and thereby a better prognosis...
  5. doi Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
    Johan Linderoth
    Department of Oncology, Lund University Hospital, Lund, Sweden
    Br J Haematol 141:423-32. 2008
    ..These findings indicate that a reactive microenvironment has an impact on the outcome of chemotherapy in DLBCL...
  6. ncbi Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma
    Johan Linderoth
    Department of Oncology, Lund University Hospital, Lund, Sweden
    Eur J Haematol 79:146-9. 2007
    ..However, a number of technical issues need to be solved before introducing this as a standard technique...
  7. doi A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus
    Mats Ehinger
    Departments of Pathology, Lund University Hospital, Lund, Sweden
    Am J Clin Pathol 129:630-8. 2008
    ..Thus, contrary to the current view, there seems to exist a certain number of cyclin D1+ and CD5- diffuse large B-cell lymphomas, some of which have structural aberrations at the CCND1 locus, including the t(11;14)...
  8. ncbi Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
    Mattias Berglund
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Mod Pathol 18:1113-20. 2005
    ..Here we confirm the prognostic importance of determining the germinal- or nongerminal center phenotype in patients with DLBCL...
  9. ncbi Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN
    Marie Fridberg
    Department of Tumor Biology, Lund University, Malmo University Hospital, Malmo, Sweden
    Leuk Lymphoma 48:2221-32. 2007
    ..For the first time, we show that ZAP70 is expressed in a higher percentage of tumor cells in the aggressive non-GC subgroup of DLBCL and that PKC-beta I and II are differently distributed in the two prognostic subgroups of de novo DLBCL...